TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,179,387
|
1,066,269
|
901,324 |
| Financial expenses |
14,606
|
23,475
|
3,679 |
| Earnings before taxes |
323,218
|
193,891
|
299,633 |
| EBITDA |
366,376
|
258,777
|
278,592 |
| Total assets |
2,642,137
|
1,991,348
|
1,517,046 |
| Current assets |
1,703,312
|
1,325,208
|
895,312 |
| Current liabilities |
602,758
|
417,197
|
314,789 |
| Equity capital |
877,882
|
1,119,402
|
1,046,481 |
| - share capital |
11,500
|
11,500
|
11,500 |
| Employees (average) |
350
|
312
|
325 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.2%
|
56.2%
|
69.0% |
| Turnover per employee |
3,370
|
3,418
|
2,773 |
| Profit as a percentage of turnover |
27.4%
|
18.2%
|
33.2% |
| Return on assets (ROA) |
12.8%
|
10.9%
|
20.0% |
| Current ratio |
282.6%
|
317.6%
|
284.4% |
| Return on equity (ROE) |
36.8%
|
17.3%
|
28.6% |
| Change turnover |
113,118
|
164,945
|
-75,865 |
| Change turnover % |
11%
|
18%
|
-8% |
| Chg. No. of employees |
38
|
-13
|
28 |
| Chg. No. of employees % |
12%
|
-4%
|
9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.